On 28 June 2023, the meeting promoted by AiSDeT (Italian Association of Digital Healthcare and Telemedicine), with the sponsorship of the University of Brescia, the Italian Association of Clinical Engineers and the Association of Management Engineers in Healthcare, was held at the University of Brescia. The theme of the meeting was ‘Governance and integration of the flow of remote patient monitoring data in the digital ecosystem of Telemedicine.
During the conference, several representatives of the healthcare sector in Italy took the floor to discuss Telemedicine, what has been achieved and the next steps to be taken to improve the quality of patient care, reduce healthcare costs, and optimise and digitalise the healthcare system.
Biotechware participated in the event by bringing the Industry point of view. Our CTO, Enrico Manzini, held the presentation ‘Telecardiology Solutions in the Hospital Environment for Pre and Post Hospitalization’ in which he illustrated the Biotechware Telemedicine Solution and various use cases in which it has been adopted and adapted to meet the needs of the healthcare facility and, consequently, the patients. The case studies presented concerned, specifically, pre-operative, pre-hospitalisation, backup service, adi and proximity and oncology monitoring. In all scenarios, Biotechware technology has contributed to process optimisation, internal resource efficiency and increased patient satisfaction.
In addition to the existing case studies, Mr Manzini presented projects in the short and long term. All of them always with a common goal: to design and develop new Telemedicine technologies in order to guarantee increasingly efficient, personalised and patient-friendly care.
Biotechware’s participation in the AiSDeT conference demonstrates the company’s commitment to providing innovative, cutting-edge solutions to improve the health and well-being of patients.
The company is proud to have contributed to this important event and to have had the opportunity to present its telemedicine solutions to an audience of industry experts.